Northwestern University Cancer Health Research SPORE (NU-CHRS)
The Northwestern University Cancer Health Research SPORE (NU-CHRS) is a National Cancer Institute–funded developmental Specialized Program of Research Excellence at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (P20CA233304). NU-CHRS will generate scientific findings and establish sustainable, collaborative, academic and community infrastructure that will serve as the foundation for a comprehensive translational cancer research program focused on gynecologic cancer health disparities — the first of its kind in the nation. The initial translational research focus of NU-CHRS is on endometrial and ovarian cancer disparities. NU-CHRS will also spearhead the development of a centralized biobank of human gynecologic cancer tissue specimens to be used in health disparities research studies.
Leadership
- Melissa Simon, MD, MPH: Principal Investigator, Administrative Core Co-Director and Developmental Research Program Co-Director
- Daniela Matei, MD: Co-Principal Investigator, Administrative Core Co-Director and Research Project 2 Basic Science Co-Leader
- Julie Kim, PhD: Developmental Research Program Co-Director and Research Project 1 Basic Science Co-Leader
- Dario Roque, MD: Research Project 1 Clinical Co-Leader
- Emma Barber, MD: Research Project 2 Clinical Co-Leader
- Jian-Jun Wei, MD: Gynecologic Biospecimen Pathology Core Co-Director
- Thomas Lad, MD: Gynecologic Biospecimen Pathology Core Co-Director, John H. Stroger, Jr. Hospital of Cook County
Research Projects
NU-CHRS teams of basic and clinical investigators conduct innovative translational research focused on understanding and reducing gynecological cancer disparities. Initial research projects focus on endometrial and ovarian cancer disparities.
Understanding Disparities in Endometrial Cancer through Tumor Genomics
Leaders: J. Julie Kim, PhD and Dario R. Roque, MD
This project investigates the biological etiology through tumor genomics and is the first comprehensive genomics analysis of endometrial tumors to study the molecular etiologies contributing to endometrial cancer disparities.
Tumor Methylomics Analysis Link With Disparities in Ovarian Cancer
Leaders: Daniela Matei, MD and Emma Barber, MD
This project focuses on epigenetic markers, particularly DNA methylation, which we hypothesize function as a link between socio-economic or environmental factors and genomic alterations to alter the course of the disease and response to therapy. We aim to identify key oncogenic drivers regulated epigenetically in tumors and generate useful new resources (organoids and patient-derived xenografts) to continue to address biological questions related to population differences in ovarian cancer response to treatment.
Gynecologic Biospecimen Pathology Core
Directors: Jian-Jun Wei, MD & Thomas Lad, MD
The Gynecologic Biospecimen Pathology Core is a collaborative effort between Northwestern University, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and John H. Stroger, Jr. Hospital of Cook County to collect gynecologic specimens from patients undergoing surgery to treat their cancer. The collection of these specimens is critical to furthering cancer disparities research that can be translated into treatment initiatives directed at improving gynecologic cancer outcomes.
Developmental Research Program
Directors: Melissa Simon, MD, MPH & J. Julie Kim, PhD
The Developmental Research Program is an incubator of novel, cutting-edge and competitive translational research of gynecologic cancer disparities. The program's mission centers on the theme of Contemporary Translational Approaches to Advancing the Detection, Diagnoses and Treatment of Gynecologic Cancers. Through this mission, merited projects with the highest probabilities of significant impact in disrupting the health disparities will be funded. It is this program's expectation that selected projects will secure more substantial funding at the end of the project period to advance the work of eliminating gynecologic cancer disparities. These funding opportunities can provide career enhancement training to scientists, clinicians and communities to support their efforts at affecting impact within gynecologic cancer disparities. It also exposes new or refocusing investigators to the rigors of NIH style review and competitive funding application process. Through educational seminars a new audience will be exposed to health disparities research, translational research and its impact on patients.
- Developmental Research Projects are collaborative, two-year, translational projects meant to produce meaningful data that can be expanded upon within additional funding at the end of the project term. The projects provide an opportunity for a basic scientist and clinician to work together to translate clinical observations into scientific demonstrations.
- Career Enhancement Projects are one-year opportunities intended to help create a career enhancement pipeline for early-stage and established investigators to enhance or refocus their career on translational research with a gynecologic cancer health disparities focus. This project pairs investigators with mentors to provide guidance and optimize the project for ultimate results for greatest impact in better understanding cancer disparities.
- Seminars & Education planning provide an opportunity to raise awareness of cancer disparities in gynecologic cancers with basic scientists, clinicians, students and community partners. Seminars will range in topics related to cancer disparities and including but not limited to basic, translational and population health sciences. As well as scientific and community based research practices and considerations.
Pilot Project Funding
NU-CHRS offers competitive funding opportunities to support projects that demonstrate high-impact innovation in clinical and basic science research and focus on a complex, poorly understood area of gynecologic cancer disparities research, in particular, ovarian, endometrial and cervical cancer research. Applications are not being accepted at this time.
Gynecologic Cancer Disparities
This initiative aims to reduce the disparities of gynecologic cancers experienced by Chicagoans by generating scientific findings and establishing sustainable, collaborative, academic and community infrastructure to serve as the foundation for focused research to identify, target and eliminate health disparities. Better insight as to the cause of a disparity leads to taking more precise action though increased screening and prevention initiatives, therapeutic development or testing via clinical trials.
Clinical Trials Participation
Increasing enrollment in clinical trials is a critical tool to eliminate gynecologic cancer disparities and lift health for all. Locally, this effort is being supported by the Health for All initiative, which provides resources and information to prospective clinical trial participants to support them in making an informed decision about participating in a clinical trial. This program aims to eliminate the barriers that limit access or awareness of clinical trials. Funding from the National Library of Medicine has supported the development of a web-based tool hat is a centralized resource to help the general public learn more about clinical trials and to specifically increase clinical trials awareness and knowledge among different populations.
Contact Information
For more information about Northwestern's Cancer Health Research SPORE and any of its programs, please contact Denisha Brown, NU-CHRS SPORE administrator, at denisha.brown1@northwestern.edu.